Management of patients with epidemic methicillin-resistant Staphylococcus aureus: experience at an infectious

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) colonization in 60 patients was studied. Most patients cleared MRSA within two months, with five or more negative weekly screenings indicating successful eradication.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant nosocomial pathogen.
  • Epidemic strains of MRSA (EMRSA) pose challenges in healthcare settings.
  • Understanding colonization and clearance is crucial for infection control.

Purpose of the Study:

  • To investigate the colonization patterns and clearance rates of an epidemic strain of MRSA (EMRSA).
  • To determine the duration of EMRSA colonization in patients admitted to an infectious diseases unit.
  • To evaluate the effectiveness of screening protocols for EMRSA eradication.

Main Methods:

  • Prospective study of 60 patients admitted between January 1983 and April 1984.
  • Patients were screened for EMRSA colonization, primarily from nasal and skin sites.
  • Weekly screening tests were used to monitor EMRSA clearance.

Main Results:

  • 38 out of 60 patients cleared EMRSA colonization in an average of 2 months.
  • 8 patients were discharged still colonized; 10 died from underlying conditions.
  • No further isolates were detected after five or more negative weekly screening tests.

Conclusions:

  • The majority of patients successfully cleared EMRSA colonization within a reasonable timeframe.
  • Five or more consecutive negative weekly screening tests are a reliable indicator of EMRSA eradication.
  • Effective management strategies can lead to successful EMRSA clearance in hospitalized patients.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...